In a recent human trial (NCT03817125), 14 patients with metastatic melanoma were treated with vancomycin followed by a combination of Ruminococcaceae-enriched bacterial communities and anti-PD-1 in the first line setting.87 The gene discussed is PDCD1; the disease is metastatic melanoma.